Organization | Stiefel Laboratories

Stiefel Laboratories Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Offenbach-am-Main Germany (1847)

Status: Acquired by GlaxoSmithKline (2009)

Organization Overview

First Clinical Trial

2004

NCT00725348

First Marketed Drug

1996

acitretin (soriatane)

First NDA Approval

1996

acitretin (soriatane)

Last Known Activity

2016

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

STIEFEL | STIEFEL LABS INC

Active Ingredients

Marketed Drugs (3)

Key: Stiefel Laboratories (2) Acquired (1)

acitretin (soriatane) (1996 NDA)

benzoyl peroxide (clearasil) (2002)

clindamycin (cleocin) (2002)

Drugs in Phase 4 Trials (12)

Key: Stiefel Laboratories (11) Acquired (1)

acitretin (soriatane) (2 trials)

adapalene (differin) (6 trials)

benzoyl peroxide (clearasil) (15 trials)

clindamycin (cleocin) (17 trials)

clobetasol (dermovate) (4 trials)

dapsone (aczone) (1 trial)

doxycycline (vibramycin) (1 trial)

etanercept (enbrel) (1 trial)

ketoconazole (nizoral) (1 trial)

miconazole (monistat) (1 trial)

tazarotene (tazorac) (9 trials)

tretinoin (Retin-A) (4 trials)

Drugs in Phase 3 Trials (7)

alitretinoin (panretin) (2 trials)

calcipotriene (dovonex) (3 trials)

dutasteride (avodart) (1 trial)

itraconazole (sporanox) (2 trials)

LIAROZOLE (1 trial)

linezolid (zyvox) (1 trial)

retapamulin (altabax) (1 trial)

Drugs in Phase 2 Trials (4)

Key: Stiefel Laboratories (3) Acquired (1)

albaconazole (3 trials)

immune globulin (human) (Gamastan) (1 trial)

talarozole (4 trials)

umeclidinium (incruse ellipta) (1 trial)

Drugs in Phase 1 Trials (6)

dexbrompheniramine (disomer) (1 trial)

sodium chloride (1 trial)

sodium monododecyl sulfate (2 trials)

tapinarof (Vtama) (2 trials)

tazorac (1 trial)

water (1 trial)

Indications

Approved Indications

Psoriasis

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 4)

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Bacterial Infections (Phase 3)

Cellulitis (Phase 3)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 1)

Dermatitis, Seborrheic (Phase 4)

Diaper Rash (Phase 4)

Eczema (Phase 3)

Hand Dermatoses (Phase 4)

Hyperhidrosis (Phase 2)

Ichthyosis (Phase 3)

Ichthyosis, Lamellar (Phase 3)

Impetigo (Phase 3)

Inflammation (Phase 1)

Onychomycosis (Phase 3)

Psoriasis (Phase 4)

Skin Diseases (Phase 4)

Skin Diseases, Infectious (Phase 3)

Tinea (Phase 1)

Tinea Pedis (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 54
# of Trial APIs: 29